Congratulations to Dr. Minhong Shen, who was approved funding from the trustees of the Elsa U. Pardee Foundation for his research project, “Delineating the Roles of Tinagl1 in Immune Checkpoint Inhibitor Therapy for Triple-negative Breast Cancer.”